Verastem Oncology
VSTM
#6555
Rank
A$1.20 B
Marketcap
A$9.56
Share price
-7.73%
Change (1 day)
-33.46%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -A$0.31 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are A$87.52 Million. In 2025 the company made an earning of -A$0.32 Billion a decrease over its 2024 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.31 Billion-5.2%
2025 -A$0.32 Billion60.57%
2024 -A$0.2 Billion49.31%
2023 -A$0.14 Billion18.36%
2022 -A$0.12 Billion3.67%
2021 -A$0.11 Billion5.43%
2020 -A$0.11 Billion-54.74%
2019 -A$0.23 Billion105.99%
2018 -A$0.11 Billion6.83%
2017 -A$0.11 Billion86.06%
2016 -A$55.06 Million-37.03%
2015 -A$87.43 Million8.43%
2014 -A$80.63 Million29.52%
2013 -A$62.25 Million28.6%
2012 -A$48.41 Million133.9%
2011 -A$20.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.52 B-3,551.52%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.19 B-820.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.80 B-3,643.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-A$12.77 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA